Your session is about to expire
← Back to Search
Procedure
Open-Lung Extubation for Collapsed Lung Prevention (OLEXT-3 Trial)
N/A
Recruiting
Led By Martin Girard, MD
Research Sponsored by Centre hospitalier de l'Université de Montréal (CHUM)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up every week. at the end of the study (average 9 months) at the study level.
Awards & highlights
No Placebo-Only Group
Summary
"This trial investigates the impact of different ventilation strategies on postoperative complications. Studies show conflicting results on the effectiveness of "open lung" ventilation in preventing atelectasis. It is important to develop evidence-based
Who is the study for?
This trial is for patients who have undergone abdominal surgery and are at risk of lung complications like collapsed lungs or injury from a ventilator. Participants must not have any conditions that would exclude them from the study, as detailed in the provided eligibility criteria.
What is being tested?
The study is testing two ways to remove breathing tubes after general anesthesia: the usual method versus a 'protective open-lung' approach designed to keep lungs well-aerated and potentially reduce post-surgery lung issues.
What are the potential side effects?
Specific side effects are not listed, but may include typical risks associated with extubation such as discomfort, coughing, or difficulty breathing immediately following tube removal.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ every week. at the end of the study (average 9 months) at the study level.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~every week. at the end of the study (average 9 months) at the study level.
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Average weekly patient recruitment rate
Postoperative pulmonary complications outcome completion rate
Protocol adherence rate
Secondary study objectives
Accuracy of self-reported protocol adherence compared to directly observed protocol adherence
Amount of supplemental oxygen administered following discharge from the post-anesthesia care unit
Days alive and out of hospital
+4 moreOther study objectives
Lowest oxygen saturation post-extubation in the operating room
Re-intubation rate in the operating room and in the post-anesthesia care unit
Time in minutes with oxygen saturation < 85% post-extubation in the operating room
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Open lung extubationExperimental Treatment1 Intervention
Before emergence from anesthesia, the patient will be positioned at 30 degrees, and oropharyngeal secretions will be suctioned. Anesthetic gas or intravenous agents will be stopped. Oxygen levels will be set to 50% with a fresh gas flow of at least 10 L/min. Ventilation mode will switch to pressure support adjusted to achieve similar volumes as controlled ventilation. PEEP levels will remain unchanged, while the minimum respiratory rate will decrease by 4 breaths/min. The inspiratory flow for triggering will be set at 2 L/min.
Group II: Conventional extubationActive Control1 Intervention
Before emergence from anesthesia, the patient will be kept supine and oropharyngeal secretions will be suctioned. Anesthetic gas or IV agents will be stopped. Oxygen concentration will be inscreased to 100% with a fresh gas flow ≥10 L/min. The ventilator will be halted, APL valve opened to atmosphere, and the patient manually ventilated with the reservoir bag until spontaneous breathing resumes, followed by manual assistance as deemed necessary by the anesthesiologist.
Find a Location
Who is running the clinical trial?
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,389 Previous Clinical Trials
26,519,228 Total Patients Enrolled
Centre hospitalier de l'Université de Montréal (CHUM)Lead Sponsor
377 Previous Clinical Trials
131,304 Total Patients Enrolled
3 Trials studying Lung Injury
30 Patients Enrolled for Lung Injury
CHU de Quebec-Universite LavalOTHER
171 Previous Clinical Trials
109,389 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger